Published in Vaccine Weekly, May 18th, 1998
Costs to society from this disease include travel to seek health care, extra diapers, loss of work time of the caregiver, and lifetime productivity of a dying child.
Roger I. Glass, MD, PhD, from the U.S. Centers for Disease Control and Prevention in Atlanta, Georgia, and colleagues conducted a cost-effectiveness analysis of a national rotavirus immunization program to estimate its economic impact. They presented...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly